Brief: China Regenerative Medicine International Entered Agreement With Shanghai Lingang Songjiang High-Tech Industry Development
16/01/2018 08:43
Jan 16 (Reuters) - China Regenerative Medicine International
Ltd 8158.HK :
* ENTERED COOPERATION FRAMEWORK AGREEMENT WITH SHANGHAI
LINGANG
SONGJIANG HIGH-TECH INDUSTRY DEVELOPMENT
* AGREEMENT FOR DEVELOPMENT & CONSTRUCTION OF SCIENCE OASIS
SITE
Source text for Eikon: ID:nHKS7m4lW4
Further company coverage: 8158.HK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on China Regenerative Medicine International
See all newsBrief: China Regenerative Medicine International Expects FY Profit To Increase At Least 28%
Brief: China Regenerative Medicine International Says Yan Shibin Will Be Appointed As CFO
Brief: China Regenerative Medicine International Posts H1 Revenue Of HKD59.78 Mln
Brief: China Regenerative Medicine International Posts FY Loss Attributable HK$107.7 Mln
Brief: China Regenerative Medicine International Says Subscription Of Increased Registered Capital